New shop cialis australia online viagradirect.net with a lot of generic and brand medications with mean price and fast delivery.

Microsoft word - bahadori babak_publ-liste

Dr. Babak Bahadori
Geb.: 25. März 1966
Publikationsliste
28. Jänner 2009

Originalarbeiten
(1) Bahadori B, Uitz E, Truschnig-Wilders M, Pilger E, Renner W. Polymorphisms of the Hypoxia
Inducible Factor Gene and Peripheral Arterial Disease. In progress. (2) Bahadori B, Uitz E, Thonhofer R, Trummer M, Pestemer-Lach I, MacCarty M, Krejs GJ.
Omega-3 fatty acids as adjuvant therapy in rheumatoid arthritis. A double-blind, randomized, placebo-controlled trial. 2008(11) JPEN akzeptiert. (3) Bahadori B, Uitz E, Tonninger-Bahadori K, Moghadasian M. Successful treatment of a morbidly
obese and growth retarded adolescent with Williams-Beuren-Syndrome (WBS) by combining the medication of Growth Hormone (GH) and Sibutramine. SMJ 2008;49(1):e15-6. (4) Thonhofer R, Kriessmayr M, Thonhofer U, Wipfler E, Uitz E, Bahadori B. Right bundle branch
block induced by low-dose methotrexate in a patient with rheumatoid arthritis. Scand J Rheumatol 2007;36(3):241-2 17657685 (5) Thonhofer R, Kriessmayr M, Thonhofer U, Wipfler E, Uitz E, Bahadori B, Eder S. Rheumatoid
arthritis patients with therapy-induced myelodysplastic syndrome present with long-term remission after recovery. Scand J Rheumatol 2007;36 (2):149-51 17476623 (6) Bahadori B, Uitz E, Tonninger-Bahadori K, Pestemer-Lach I, Trummer M, Thonhofer R, Brath
H, Schaflinger E. Body Composition: The fat free mass iIndex (FFMI) and the body fat mass index (BFMI) distribution among the Austrian population - results of a cross-sectional study. Int J Body Comp Res 2006 Vol. 4 No. 3: 123-128. (7) DeClercq V, Yeganeh B, Moshtaghi-Kashanian GR, Bahadori B, Moghadasian M. Paradoxical
Effects of Fenofibrate and Nicotinic Acid in Apo E-Deficient Mice. J Cardiovasc Pharmacol 2005 Jul;46(1):18-24. (8) Bahadori B, Yazdani-Biuki B, Krippl P, Brath H, Uitz E and Wascher TC. Low-fat, high-
carbohydrate (low-glycemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24-week study. Diab Obes Metab. 2005;May;7(3):290-3. (9) Bahadori B, Trinker M, Wallner SJ, Yazdani-Biuki B and Wascher TC. Diabetes mellitus and
weight control: Differences of respiratory quotient (RQ) in type-II-diabetic obese subjects receiving sulfonylureas and non-diabetic obese controls. Nutrition. 2003 Feb;19(2):159-60. (10) Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Bahadori B, Samonigg H. The L10P polymorphism of the transforming growth factor-beta 1
gene is ot associated with breast cancer risk. Cancer Lett 2003 Nov; 25;201(2):181-4
(11) Zapotoczky H, Semlitsch B, Herzog G, Bahadori B, Siebenhofer A, Pieber TR, Zapotoczky HG:
A controllled study of weight reduction in type 2 diabetics treated by two reinforces. Internat Journ of Behav Med 2001; 8(1);42-49 (12) Leitner GC, Roob JM, Bahadori B, Wallner S, Wascher TC. Leptin deficiency due to lipid
apheresis: a possible reason for ravenous hunger and weight gain. Int J Obes Relat Metab Disord. 2000 Feb;24(2):259-60. (13) Wascher TC, Bammer R, Stollberger R, Bahadori B, Wallner S, Toplak H. Forearm composition
contributes to differences in reactive hyperaemia between healthy men and women. Eur J Clin Invest. 1998 Mar;28(3):243-8. (14) Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H. [Effect of chromium yeast and
chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet]. Acta Med Austriaca. 1997;24(5):185-7.
(15) Wascher TC, Graier WF, Dittrich P, Hussain MA, Bahadori B, Wallner S, ToplakH. Effects of
low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity. Eur J Clin Invest. 1997 Aug;27(8):690-5. (16) Wascher TC, Bahadori B, Habersack-Wallner S, Toplak H. Oral L-arginine supplementation in
chronic heart failure. Circulation. 1997 Mar 18;95(6):1674-5 (17) Toplak H, Bahadori B, Wascher TC. CAPRIE trial. Lancet. 1997 Feb 1;349(9048):354;
(18) Bahadori B, Neuer E, Schumacher M, Fruhwald F, Eber B, Klein W, Topak H, Wascher TC.
Prevalence of coronary artery disease in obese versus lean men with angina pectoris and positive exercise stress test. Am J Cardiol. 1996 May 1;77(11):1000-1. (19) Bahadori B, Smolle KH, Habersack-Wallner SJ, Toplak H, Wascher TC: Randomisierter
Vergleich einer "Very-low-calorie-diet" (Modifast) und einer intensivierten Diättherapie auf Gewichtsverlust und Atherosklerose-Risikoparameter bei adipösen Patienten einer Stoffwechselambulanz. Aktuelle Ernährungsmedizin, 1996; 21, 93-97. (20) Toplak H, Haller EM, Lauermann T, Weber K, Bahadori B, Reisinger EC, Tilz GP, Wascher TC.
Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients. Diabetes Res Clin Pract. 1996 Apr;32(1-2):97-101. (21) Toplak H, Wascher TC, Weber K, Lauermann T, Reisinger EC, Bahadori B, Tilz GP, Haller EM.
[Increased prevalence of serum IgA Chlamydia antibodies in obesity]. Acta Med Austriaca. 1995;22(1-2):23-4. (22) Wascher TC, Graier WF, Bahadori B, Toplak H. Time course of endothelial dysfunction in
diabetes mellitus. Circulation. 1994 Aug;90(2):1109-10. (1) Mein Körper in Balance. Ärzteverlag, erschienen September 2008. (2) The 7 Steps To Balance. 1. Auflage. Eigenverlag Bahadori, November 2007 (3) Die 7 Stufen zu Ihrem Gleichgewicht. 3. Auflage. Eigenverlag Bahadori, Oktober 2005 (4) Die 7 Stufen zu Ihrem Gleichgewicht. 2. Auflage. Eigenverlag Bahadori, Dezember 2004 (5) Die 7 Stufen zu Ihrem Gleichgewicht. 1. Auflage. Eigenverlag Bahadori, Sommer 2003 (6) Richtlinien der Antioxidanzientherapie für die Praxis. Eigenverlag Bahadori, Oktober 2001 Buchbeiträge
Kapitel „Metabolisches Syndrom“. Ernährungsmedizin. Verlag der Österreichischen Ärztekammer, 2. Auflage, 2005 Kapitel „Metabolisches Syndrom“. Ernährungsmedizin. Verlag der Österreichischen Ärztekammer, 1. Auflage, 2001 (1) Wascher TC, Bahadori B, Wallner SJ, Toplak H: L-arginine supplementation in chronic heart
failure. Circulation, 95, 1674, 1997 (Letter) Weitere Veröffentlichungen
(1) Bahadori B, Dam K. Jenseits von Cholesterin - Arteriosklerose und Omega-3 Fettsäuren. Arzt
(2) Bahadori B. Moderate Ausdauerbewegung fördert die Fettoxidation. Ärztemagazin, 2006(17)
(3) Bahadori B. Niedriger glykämischer Index und fettreduziert - Kommt die neue Diätform?
(4) Bahadori B, Uitz E. Adipositas: Magnesium optimiert die Stoffwechsellage. Ärztemagazin,
(5) Bahadori B. Adipositas: Gemeinsam gegen die neue Epidemie! Top Medizin, 2001(12)
(6) Bahadori B. Adipositas erfolgreich bekämpfen. Gewicht reduzieren auf die sanfte Tour! Medical
(7) Wallner SJ, Bahadori B, Steinberger I, Lahousen T, Krejs GJ. Adipositastherapie: Nahrung als
Intervention. J Ernährungsmed 2001;4:11-6 (8) Toplak H, Wascher TC, Bahadori B, Wallner SJ: Die orale antidiabetische Ersteinstellung.
(9) Wascher TC, Bahadori B, Habersack-Wallner SJ, Toplak H: Gefäßerkrankungen bei Diabetes
Mellitus - Die Atherosklerose des Diabetikers. Forum Dr. Med., 20 (16) 14-22, 1996 (10) Wascher TC, Bahadori B, Habersack-Wallner SJ, Toplak H: Gefäßerkrankungen bei Diabetes
Mellitus - Die diabetische Mikroangiopathie. Forum Dr. Med., 20, 12: 34-40, 1996 (11) Toplak H, Bahadori B, Habersack-Wallner SJ, Wascher TC: Therapie der Lipidstoffwechsel-
störungen. Forum Dr. Med., 20, 8: 14-21, 1996 (12) Habersack-Wallner SJ, Wascher TC, Bahadori B, Toplak H: Formuladiäten. Forum Dr. Med.,
(13) Toplak H, Wascher TC, Bahadori B, Habersack-Wallner SJ: Orale Antidiabetika. Forum Dr.
Abstrakts
(1) Uitz E, Bahadori B, Thonhofer R, Trummer M, Pestemer-Lach I, MacCarty M, Krejs G. Omega-
3 fatty acids as adjuvant therapy in rheumatoid arthritis. a double-blind, randomized, placebo-controlled trial. EULAR 2006, Amsterdam. Ann Rheum Dis 2006;65(Suppl II):347 (2) Thonhofer R, Kriessmayr M, Thonhofer U, Wipfler E, Uitz E, Bahadori B, Eder S. RA-patients
with therapy induced MDS present with long-time remission after recovery - a report of two cases. EULAR 2006, Amsterdam. Ann Rheum Dis 2006;65(Suppl II):490 (3) Yazdani-Biuki B, Bahadori B, Mulabecirovic A, Brezinschek HP. Isoprostane as a marker of disease activity in SLE patients. Arthr Rheum 2003 48: 1488-1488. (4) Wallner SJ, Wagner KH, Aigner R, Smolle KH, Uitz E, Bahadori B, Krejs GJ: Anorexia Nervosa
(AN): Model of Malnutrition and Oxidative Stress. Aktuel Ernähr Med, 27: 113, P7, 2002 (5) Wallner SJ, Lipp RW, Tafeit E, Bahadori B, Hacker C, Krejs GJ: Beeinflussung der
Magenentleerungsrate nach der Einnahme von CM3-Zellulose und postprandialem Walking bei Normalgewichtigen und Adipositas. ÖGGH, 2001 (6) Bahadori B, Wallner SJ, Smolle KH, Bös U, Schaflinger E, Wascher TC: Indirekte Kalorimetrie
bei übergewichtigen Typ II Diabetikern und einem gesunden Kontrollkollektiv. Acta Med. A, 2000 Bahadori B, Wallner S, Hacker C, Boes U, Komorowski JR, Wascher TC. Effects of chromium
picolinate on insulin levels and glucose control in obese patients with type-II diabetes mellitus.
Diabetes 1999;48(suppl):A349 (abstr).
(8) Bahadori B, Wallner SJ, Barowitsch C, Füger G, Wascher TC: The impact of high dose oral
melatonin on plasma concentrations of alpha-melanocyte-stimulating hormone. Int Journ Obes, Volume 22, suppl.3, P356, 1998 (9) Boes U, Wonisch W, Wallner SJ, Bahadori B, Wascher TC: The effect of a high-fat dinner on
nocturnal plasma peroxide levels in healthy subjects. Int Journ Obes 1998; Vol 22, Suppl.3, 333. (10) Wascher TC, Wallner SJ, Bahadori B, Toplak T: No effect of meal size or composition on
postprandial serum leptin concentrations in healthy subjects. Int Journ Obes 1998; Vol 22, Suppl 3, 289. (11) Wallner SJ, Smolle KH, Bahadori B, Wascher TC: Indirect calorimetry in overweight diabetic
and nondiabetic subjects. Int Journ Obes 1998; Vol 22, Suppl 3, 223. (12) Wascher TC, Wallner SJ, Bahadori B, Roden M, Novotny P, Toplak H: Effects of melatonin
supplementation on plasma leptin levels. Diabetologia, 40 (suppl 1), A270, 1997 (13) Bahadori B, Wallner SJ, Roden M, Novotny P, Toplak H, Wascher TC: Impact of melatonin
supplementation on leptin levels duri ng prolonged fasting. 4th IBC-Symposium on Obesity Boston, abstract, 1997 (14) Bahadori B, Wascher TC, Wallner SJ, Roden M, Novotny P, Toplak H: Die Einflußnahme von
hochdosierter Melatoningabe auf die Plasmaleptinspiegel bei prolongiertem Fasten. Acta Med Austriaca 24 (suppl 45), 17, 1997 (15) Wascher TC, Wallner SJ, Bahadori B, Roden M, Novotny P, Toplak H: Effects of melatonin
supplementation on plasma leptin levels. Diabetologia, 40 (suppl. 1), A270, 1997 (16) Habersack SJ, Bahadori B, Schneider H, Wascher TC, Toplak H: Effects of chromium yeast and chromium picolinate on insulin sensitivity in obese non-diabetic patients. 2nd IBC-Symposium on Obesity. Washington, abstract, 1996 (17) Bahadori B, Habersack SJ, Schneider H, Wascher TC, Toplak H: Effects of chromium yeast
and chromium picolinate on body composition in obese non-diabetic patients under weight reduction. 2nd IBC-Symposium on Obesity. Washington, abstract, 1996 (18) Habersack-Wallner SJ, Kreuz E, Graier W, Bahadori B, Toplak H, Wascher TC:Superoxide
scavenging effects of free aminoacids. Diabetologia, 39 (suppl 1), A225, 1996 (19) Habersack-Wallner SJ, Kreuz E, Graier WF, Bahadori B, Toplak H, Wascher TC: Superoxide
scavenging effects of free aminoacids. Diabetologia, 39 (suppl. 1), A225, 1996 (20) Bahadori B, Habersack-Wallner SJ, Schneider H, Wascher TC, Toplak H: Chrom-Picolinat
verbessert die "Lean-Body-Mass" nach Gewichtsreduktion mit Modifast®, AMA, 22 (Suppl.1), 45, 1995 (21) Wascher TC, Bahadori B, Habersack-Wallner SJ, Schneider H, Toplak H: Chrom-Picolinat als
Zusatz zu einer Gewichtsreduktion mit Modifast® verbessert die Insulin-Glucose Ratio. AMA, 22 (Suppl.1), 45, 1995 (22) Toplak H, Habersack-Wallner SJ, Bahadori B, Schneider H, Wascher TC: Addition of
Chromium-Picolinate to a very low calorie diet improves the insulin-glucose ratio after weight reduction. Int J Obesity, 19 (Suppl.2), 38, 1995 (23) Bahadori B, Habersack-Wallner SJ, Schneider H, Wascher TC, Toplak H. Treatment with
chromiumpicolinate improves lean mass in patients following weight reduction. /nt J Obesity 1995;19(suppl 2):38. (24) Wascher TC, DeCampo A, Bahadori B, Habersack-Wallner SJ, Weber K, Krejs GJ, Toplak H:
Atherosklerotische Risikoparameter sind bei Typ-I und Typ-II Diabetes unterschiedlich von der Diabeteseinstellung abhängig. AMA, 21 (Suppl. 1), 10, 1994 (25) Bahadori B, DeCampo A, Wascher TC, Habersack-Wallner SJ, Weber K, Krejs GJ, Toplak H:
Mittleres Thrombozytenvolumen als neuer vaskulärer Risikofaktor-Effekte von Diabetes mellitus und Stoffwechselkontrolle. AMA, 21 (Suppl. 1), 10, 1994 (26) Toplak H, Bahadori B, Weber K, Habersack-Wallner SJ, Krejs GJ, Wascher TC:
Gewichtsreduktion mittels "very low calory diet" und konventioneller Gewichtsreduktion-randomisierte, einjährige, monozentrische Vergleichsstudie. AMA, 21 (Suppl. 1), 9, 1994 (27) Bahadori B, Wascher TC, Weber K, Habersack-Wallner SJ, Toplak H: Effects of a very-low-
calory-diet and conventional weight reduction on mean platelet volume in obese patients. Int J Obesity, 18 (Suppl.2), 138, 1994

Source: http://www.die7stufen.at/downloads/DrBahadoriPublications.pdf

Bone health is a family affair

Department of Biostatistics is conducting a research project on osteoporosis. If you are eligible to participate you would receive at no cost to you a Bone Health Assessment which includes a bone density test. You will receive compensation for the one-time, 2 hour visit. Weekday, evening, and weekend appointment times are available. Eligible subjects must meet the fo

Esoterica - condições gerais - v20140124

Condições Gerais Registo de Domínios e Serviços de Alojamento As presentes Condições Gerais estabelecem o Acordo entre o Cliente e a Clara.net Portugal – Telecomunicações, S.A. (Claranet). Os Serviços prestados ao abrigo destas Condições Gerais são geralmente identificados pela marca comercial ESOTERICA. A ESOTERICA é uma marca registada da Claranet. Ao preencher o Formul

Copyright © 2010-2014 Pdf Physician Treatment